🇺🇸 FDA
Patent

US 6140339

Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof

expired A61KA61K31/47A61P

Quick answer

US patent 6140339 (Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 31 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/47, A61P, A61P33/06